Kaiser Permanente is proud to partner with the Program on Regulation, Therapeutics, and Law (PORTAL), out of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital/Harvard Medical School, to uncover trends in pharmaceutical evidence generation and highlight the clinical benefits associated with newly approved drugs. Through this partnership, the PORTAL team has published five prominent peer-reviewed studies so far.
